Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“Think about this statistic the next time someone recommends surgery for an adrenal metastasis.
Excited to be a part of this collaboration with friends and colleagues in Amsterdam. It isn’t inspired entirely to advance SABR in place of surgery; instead, it is about identifying how often adrenalectomies end up with positive margins and local recurrence. The preliminary data shows it happens >50% of the time.”
Title: Efficacy and safety of surgery versus stereotactic ablative radiotherapy (SABR) for adrenal metastases: a systematic review and meta-analysis.
Authors: Nicolas Giraud, Sasha Ebrahimi, Famke Schneiders, Drew Moghanaki, Suresh Senan
Read the Full Article in NIHR.
More posts featuring Drew Moghanaki.